Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Reimbursement thinking for medtech designers and engineers

August 3, 2016 By Rogene Evans

Heather Thompson | Senior Editor | Medical Design & Outsourcing |

Heather Thompson | Senior Editor | Medical Design & Outsourcing |

Reimbursement is a dreaded topic for designers and engineers, says Mike Drues, president of Vascular Sciences. “It can be boring because people approach it like it is a box to check.” But, he says, it’s not just about the money and checking boxes. “Engineers have to care about reimbursement, because it’s fundamental to ensuring that the products developed actually get to the patients that need the technology.”

In the U.S., we think we have the best medical technology money can buy, says Drues. But that’s not entirely true. “We have the best medical technology that money is willing to buy.”

That’s not necessarily a bad thing, he adds, just the result of dealing with the system that’s in place. And, as such, there are fundamental considerations, such as reimbursement, that need practical consideration even from a design standpoint.

Reimbursement is the principle of establishing or aligning technology with a code. Those codes (e.g., ICD-9, ICD-10) are used in documenting diagnoses and procedures in a healthcare setting. And those codes and the path to getting those codes must be part of the design and development discussion, says Drues. “It’s not sufficient to design a better mousetrap, especially if a product is expensive,” he says. “There are plenty of innovative devices that could be designed, but they aren’t in development because there’s no business case for them.”

In fact, Drues says, one of the fundamental innovation questions designers should ask is, “What are we NOT developing, and why?” The answer might be that the business isn’t worth it.

This might be particularly true if you are trying to fit your technology into an existing code. Drues explains that existing codes can be a double-edged sword. “I’m often asked whether it’s better to fit the reimbursement code or to create a new one,” he says. The advantage of an existing code is that it works within an established framework – it’s easily understood by all stakeholders. The disadvantage is that if you get existing coverage, you get existing payments. “So if a treatment is on the market for $19 for an office-based procedure, you really can’t make a business case of why you should get more for treating the same disease in a similar way.”

And, he says, although no one gets to pick their code, if companies are prepared they can suggest proper codes to CMS.

Think early, but don’t act until you’re ready
“One of the most common questions I get is, ‘When should I start thinking about regulation or reimbursement?’” says Drues. His response to that question is always, “You can’t think about it soon enough.” He advises companies to integrate and time regulations and reimbursement together.

Thinking about it is one thing. Taking action, however is another, says Drues. “You can’t think about it too soon, but you shouldn’t go to FDA or CMS one day sooner than you are able to present your plan and strongly defend it.”

This is a delicate part of the strategy, he notes. “I won’t go to FDA or CMS until I’ve able to say, ‘This is what we need to do and why we should do it.’”

Don’t ask, present
“The most important thing is not to ask FDA (or CMS) what to do,” says Drues. He says the agencies are directional, not dictatorial. The earlier you consider reimbursement, the better chance you have of figuring out what course of action makes sense for the product. It also helps if companies conclude that they might need to deviate from the normal process – and have a good reason why.

For example, he says that sometimes reimbursement can come first. “I’ve gone to CMS before FDA in order to get the details about what clinical evidence CMS needs to see for reimbursement.” He explains that for a particular product he was working on, the 510(k) was a simple process. So instead of going to FDA, he went to CMS to come to agreement on the study the agency needed to see to get the proper code. “Then I went to FDA and told them the clinical trial we were planning (based on CMS input). We looked like heroes.”

Ultimately, he says, you have to be able to sell the agency on your strategy. “It is your job to think about what you are doing, and come up with the best strategy for regulation and reimbursement, not FDA or CMS.” Then you go to the agencies and say, “this is what makes sense.” He says companies should be definitive and convince FDA or CMS of the correct path, and that can only come if that strategy has been thought about from a design perspective.

Related Articles Read More >

This image shows the logo of AdvaMed and the flags of the United States, Switzerland and United Kingdom as AdvaMed works with fellow medtech trade associations at top trade partners to shield the medical device industry from global trade wars.
AdvaMed seeks closer medtech ties with top trading partners
This is the logo of Siemens Healthineers.
Siemens Healthineers reports higher pay for some executives, lower pay for others
Big 100: Henry Schein logo - Largest Medical Device Companies
Henry Schein discloses pay hikes for top leaders
Big 100: Owens & Minor logo - Largest Medical Device Companies
Owens & Minor executive pay disclosure includes severance for C-suite ouster
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe